Reduction of podocyte globotriaosylceramide content in adult male patients with Fabry disease with amenable GLA mutations following 6 months of migalastat treatment

Michael Mauer, Alexey Sokolovskiy, Jay A. Barth, Jeffrey P. Castelli, Hadis N. Williams, Elfrida R. Benjamin, Behzad Najafian

Research output: Contribution to journal › Article › peer-review

27 Scopus citations

Fingerprint

Dive into the research topics of 'Reduction of podocyte globotriaosylceramide content in adult male patients with Fabry disease with amenable GLA mutations following 6 months of migalastat treatment'. Together they form a unique fingerprint.

Medicine & Life Sciences